XML 18 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Cash flows from operating activities:    
Net loss $ (13,301) $ (11,227)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 95 135
Noncash interest expense 281 244
Amortization of intangible assets 152 152
Inventory excess and obsolescence charge 767 916
Change in fair value of warrants   38
Stock‑based compensation expense 943 119
Change in operating assets and liabilities:    
Accounts receivable 238 (599)
Inventory (750) (1,169)
Prepaid expenses and other assets 823 (156)
Accounts payable (2,096) (1,312)
Accrued expenses and other liabilities (859) (123)
Foreign currency remeasurement loss 45  
Net cash used in operating activities (13,662) (12,982)
Cash flows from investing activities:    
Proceeds from the sale and maturity of short-term investments 9,289  
Payment for intangible asset   (500)
Purchase of property and equipment (96) (89)
Net cash provided by (used in) investing activities 9,193 (589)
Cash flows from financing activities:    
Proceeds from underwritten public offering, net of underwriting discounts, commissions and offering costs 45,120  
Payment of initial public offering costs (522)  
Proceeds from issuance of Series B redeemable convertible preferred stock, net of offering costs   12,158
Proceeds from exercise of stock options 44 8
Net cash provided by financing activities 44,642 12,166
Effect of exchange rate on cash (4)  
Net increase (decrease) in cash and cash equivalents 40,169 (1,405)
Cash and cash equivalents, beginning of period 45,302 17,278
Cash and cash equivalents, end of period 85,471 15,873
Supplemental disclosure of cash flow information:    
Cash paid during the period for interest 1,482 1,582
Supplemental disclosures of noncash investing and financing activities:    
Accretion of redeemable convertible preferred stock   4,787
Offering costs in accounts payable and accrued expense and other current liabilities 398 32
Intangible assets in accrued expenses and other liabilities   2,000
Issuance of common stock for early exercised stock options $ 2 $ 3